A Clinical Update on Vitrectomy for Diabetic Retinal Disease
Patient selection can significantly impact outcomes.
A Day With Didier Ducournau, MD
Vitrectomy a Frenchman’s way
Clinical Update on the Removal of IOFBs
A comprehensive guide to diagnosis and treatment
CODING Q&A
Microperimetry Utility and Reimbursement
Evidence-based Treatment of RVO With Anti-VEGF Drugs
In the first of two parts, we cover the evidence for treating branch RVO.
ILM Peeling and Multifocal IOLs
Visualization can be difficult to obtain in such cases.
Image Management Systems in Retinal Practices
Is now the time to consider one?
Imaging of Intraocular Tumors
Proper imaging studies can be the key to diagnosis.
JOURNAL CLUB
RECENT NOTEWORTHY STUDIES TO STIMULATE DISCUSSION AND DEBATE
SUBSPECIALTY NEWS
By Jerry Helzner, contributing editor
UPFRONT
According to Plan
AGTC: Gene Replacement For Orphan Retinal Diseases
The company is about to begin human clinical trials.
By Jerry Helzner, contributing editor
Daniel M. Schwartz, MD: UCSF and Caltech
Successful innovation in an academic setting.
By Jerry Helzner, contributing editor
Dr. Eugene de Juan, Jr.: A Lifelong Quest to Innovate
By Jerry Helzner, contributing editor
Dr. Gil Kliman and InterWest Partners
Following anterior-segment successes, retinal disease becomes a focus.
By Jerry Helzner, contributing editor
Dr. Vernon G. Wong: A Pioneer in Sustained-Release Therapy
After Ozurdex success, he seeks new challenges to tackle.
By Jerry Helzner, contributing editor
Drs. Michael Trese and George Williams
Ocriplasmin: two decades of commitment to a concept.
By Jerry Helzner, contributing editor
George D. Yancopoulos, MD, PhD, And the Regeneron Story
By Jerry Helzner, contributing editor
Hampar and Vicken Karageozian
The father-son team behind Allegro Ophthalmics
By Jerry Helzner, contributing editor
J. Andy Corley: From Refractive to Retina
A proven innovator enters a new arena.
By Jerry Helzner, contributing editor
Mark S. Blumenkranz: A Series of Successes
By Jerry Helzner, contributing editor
New Approaches to Treating Wet AMD
Combination therapies and gene replacement hold promise.
By Jerry Helzner, contributing editor
Refining Retina: Lessons from the Mouse
By Pravin U. Dugel, MD
Samir Patel: A Pioneer in Anti-VEGF
By Jerry Helzner, contributing editor
The Ophthalmology Innovation Summit
OIS presentations preview the future of retina.
By Jerry Helzner, contributing editor
Venture Capital Is Catalyst That Spurs Major Advances
By Jerry Helzner, contributing editor